Omega-3 Fatty Acids May Reduce Risk of Chronic Kidney Disease
Healthcare
Breyanzi meets primary endpoint in pivotal trial for patients with R/R CLL
BMS is confident that Breyanzi monotherapy can be a one-time administered therapy for R/R CLL patients.
Five gene therapy trial readouts to watch in the first half of 2023
New prostate cancer risk prediction tool identifies men at highest risk
Study explores relationship between particulate matter and childhood asthma
Enlivex receives approval for Phase I/II solid tumour trial in Israel
Nanoscope doses first subject in Phase II Stargardt disease trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
